Ten-year follow-up survival of the medicine, angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease

Circulation

Volumn 122, Issue 10, 2010, Pages 949-957

  Hueb, Whady ^a   Lopes, Neuza ^a   Gersh, Bernard J ^b   Soares, Paulo R ^a   Ribeiro, Expedito E ^a   Pereira, Alexandre C ^a   Favarato, Desiderio ^a   Rocha, Antonio Sérgio C ^a   Hueb, Alexandre C ^a   Ramires, Jose A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MAYO CLINIC   (United States)

Author keywords

angioplasty; bypass; drugs; heart diseases; surgery

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASODILATOR AGENT;

ADULT; ANGIOPLASTY; ARTICLE; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART EJECTION FRACTION; HEART INFARCTION; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REVASCULARIZATION; STABLE ANGINA PECTORIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; AGED; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG COMBINATION; HOSPITALIZATION; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 77957281711     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.911669     Document Type: Article

References (24)

1. Booth J, Clayton T, Pepper J, Nugara F, Flather M, Ulrich S, Stables RH; on behalf of the SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation. 2008;118:381-388.
2. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx B, Hugenholtz PG, Firth BG, Unger F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575-581.
3. Rodriguez AE, Baldi J, Fernandez Pereira C, Navia J, Rodriguez Ale-mparte M, Delacasa A, Vigo F, Vogel D, O'Neill W, Palácios IF. Five-year follow-up of the Argentine randomized trial of coronary angio-plasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005;46:582-588.
4. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.
5. Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082-1089.
6. Hueb W, Soares PR, Gersh BJ, Cesar LAM, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JAF. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease. J Am Coll Cardiol. 2004;43:1743-1751.
7. Douglas JR Jr, King SB III, Roubin GS. Technique of percutaneous transluminal angioplasty of coronary, renal, mesenteric, and peripheral arteries. In: Hurst JW, Schlant RC, Rackely CE, eds. The Heart. 7th ed. New York, NY: McGraw-Hill; 1990:2131-2153.
8. Jones EL, Craver JM, King SB III, Douglas JS, Bradford JM, Brown CM, Bone DK, Hatcher CR Jr. Clinical, anatomic and functional descriptors influencing morbidity, survival and adequacy of revascularization following coronary bypass. Ann Surg. 1980;192:390-402.
9. Dodge HT, Sandler HS, Baxley WA, Hawley RR. Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol. 1966;18:10-24.
10. Campeau L. Grading of angina pectoris. Circulation. 1976;54:522-523. Letter.
11. Hoffman SN, Tenbrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293-1304.
12. Bravata DM, Gienger AL, McDonald KM, Sundaram V, Perez MV, Varghese R, Kapoor JR, Ardehali R, Owens DK, Hlatky MA. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147: 703-716.
13. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, Hueb WA, Lemos PA, Serruys PW. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II and SoS trials. Circulation. 2008;118:1146-1154.
14. Hlatky MA, Boothroyd DB, Bravata D, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin MN, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomized trials. Lancet. 2009;373:1190-1197.
15. BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49:1600-1606.
16. Rogers WJ, Coggin CJ, Gersh BJ, Fisher LD, Myers WO, Oberman A, Sheffield LT. Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery: the Coronary Artery Surgery Study (CASS). Circulation. 1990;82:1647-1658.
17. Gersh BJ, Frye RL. Methods of coronary revascularization: things may not be as they seem. N Engl J Med. 2005;352:2235-2237.
18. Van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002;39:559-564.
19. Vander Salm TJ, Kip KE, Jones RH, Schaff HV, Shemin RJ, Aldea GS, Detre KM. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2002;39:565-572.
20. Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts have an increase occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation. 2004;109:2086-2091.
21. Boden WE, O'Rourke RA, Teo KK, Maron DJ, Hartigan PM, Sedlis SP, Dada M, Labedi M, Spertus JA, Kostuk WJ, Berman DS, Shaw LJ, Chaitman BR, Mancini GB, Weintraub WS; COURAGE Trial Investigators. Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial). Am J Cardiol. 2009;104:1-4.
22. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503-1516.
23. BARI 2D Study Group; Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, Nesto RW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503-2515.
24. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of ran domized trials and observational studies. Circulation. 2009;119:3198-3206.